Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie Perry

Showing results (401-410 of 422) with videos related to

Pageof 43
Sort By:
Acta Neuropathologica|January 27, 2016
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphologyIbrahim Qaddoumi, Wilda Orisme, Ji Wen, et al.
Nature Communications|January 12, 2024
Epigenetic reprogramming shapes the cellular landscape of schwannomaS John Liu, Tim Casey-Clyde, Nam Woo Cho, et al.
The New England Journal of Medicine|June 11, 2015
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in TumorsJeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, et al.
Acta Neuropathologica|August 9, 2022
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1Calixto-Hope G Lucas, Emily A Sloan, Rohit Gupta, et al.
Acta Neuropathologica|April 19, 2020
Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibitionGourish Mondal, Julieann C Lee, Ajay Ravindranathan, et al.
Neuro-Oncology|July 12, 2023
Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programsErik A Williams, Ajay Ravindranathan, Rohit Gupta, et al.
Nature Genetics|May 9, 2022
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilitiesAbrar Choudhury, Stephen T Magill, Charlotte D Eaton, et al.
Acta Neuropathologica|September 14, 2019
Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomasEmily A Sloan, Tabitha Cooney, Nancy Ann Oberheim Bush, et al.
Acta Neuropathologica Communications|August 30, 2020
Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumorCalixto-Hope G Lucas, Rohit Gupta, Pamela Doo, et al.
Acta Neuropathologica|May 21, 2014
CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entityTara Spence, Patrick Sin-Chan, Daniel Picard, et al.
Pageof 43

Showing results (401-410 of 422) with videos related to

Sort By:
Pageof 43
Acta Neuropathologica|January 27, 2016
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphologyIbrahim Qaddoumi, Wilda Orisme, Ji Wen, et al.
Nature Communications|January 12, 2024
Epigenetic reprogramming shapes the cellular landscape of schwannomaS John Liu, Tim Casey-Clyde, Nam Woo Cho, et al.
The New England Journal of Medicine|June 11, 2015
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in TumorsJeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, et al.
Acta Neuropathologica|August 9, 2022
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1Calixto-Hope G Lucas, Emily A Sloan, Rohit Gupta, et al.
Acta Neuropathologica|April 19, 2020
Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibitionGourish Mondal, Julieann C Lee, Ajay Ravindranathan, et al.
Neuro-Oncology|July 12, 2023
Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programsErik A Williams, Ajay Ravindranathan, Rohit Gupta, et al.
Nature Genetics|May 9, 2022
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilitiesAbrar Choudhury, Stephen T Magill, Charlotte D Eaton, et al.
Acta Neuropathologica|September 14, 2019
Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomasEmily A Sloan, Tabitha Cooney, Nancy Ann Oberheim Bush, et al.
Acta Neuropathologica Communications|August 30, 2020
Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumorCalixto-Hope G Lucas, Rohit Gupta, Pamela Doo, et al.
Acta Neuropathologica|May 21, 2014
CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entityTara Spence, Patrick Sin-Chan, Daniel Picard, et al.
Pageof 43